Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  pan FGFR inhibitor ARQ 087
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Phase 1 Dose Escalation Study of ARQ 087 in Adult Subjects With Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ARQ 087-101, NCI-2013-00121, NCT01752920
Start Over